Science Explorer Back to mapMap
Discussion
Researcher · IRCCS Ospedale San Raffaele · Italy

Mike Bigler

Mike Bigler publishes mostly in Immunology, Epidemiology and Hematology, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and Immunotherapy and Immune Responses.

OpenAlex
World rank
#910,633
of 7,710,434 ranked researchers
Rank in Italy
#28,099
of 242,206
Works
22
Citations
6.7k
Citations per work
306.5
h-index
17
i10-index 17Top 40% in Immunology
Mike Bigler

What does Mike Bigler research?

Mike Bigler's work is mostly in Immunology and Microbiology (69%), Medicine (16%), Neuroscience (3%).

Life Sciences: 16 works · 74.2% of their workImmunology and Microbiology: 15 works · 69.4% of their workImmunology: 15 works · 69.4% of their workNeuroscience: 1 works · 3.2% of their workNeurology: 1 works · 3.2% of their workBiochemistry, Genetics and Molecular Biology: 0 works · 1.6% of their workMolecular Biology: 0 works · 1.6% of their workHealth Sciences: 4 works · 17.8% of their workMedicine: 4 works · 16.2% of their workEpidemiology: 2 works · 9.7% of their workHematology: 1 works · 6.5% of their workHealth Professions: 0 works · 1.6% of their workEmergency Medical Services: 0 works · 1.6% of their workEverything else: 2 works · 8.0% of their workTHEIR WORKMike Bigler22works
Life Sciences74%Health Sciences18%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology1569.4%
    2. Neuroscience13.2%
    3. Biochemistry, Genetics and Molecular Biology01.6%
    1. Medicine416.2%
    2. Health Professions01.6%
  3. Everything else28.0%
  1. 1Immunology69% of their works
  2. 2Epidemiology10% of their works
  3. 3Hematology6% of their works
  4. 4Neurology3% of their works
  5. 5Emergency Medical Services2% of their works
  6. 6Molecular Biology2% of their works

Research topics

Which keywords describe Mike Bigler's research?

The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, Foxp3, TGF-ß, Immunity, Cancer Immunotherapy, Dendritic Cells and Bone Marrow Niche.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. NK Cell Recognition161 topic
  2. Natural Killer Cells161 topic
  3. Foxp3121 topic
  4. TGF-ß121 topic
  5. Immunity82 topics
  6. Cancer Immunotherapy61 topic
  7. Dendritic Cells61 topic
  8. Bone Marrow Niche41 topic
  9. Cytomegalovirus41 topic
  10. Genetic Mutations41 topic
  11. Hematopoietic Stem Cells41 topic
  12. Infection41 topic
  13. Inflammation42 topics
  14. Primary Immunodeficiency41 topic
  15. Activation21 topic
  16. Macrophage21 topic
  17. Pattern Recognition Receptors21 topic
  18. Toll-like Receptors21 topic

Where does Mike Bigler work?

Mike Bigler's main affiliation in the publication record is IRCCS Ospedale San Raffaele, Italy.

How many publications and citations does Mike Bigler have?

OpenAlex counts 22 works and 6,742 citations for Mike Bigler, an h-index of 17, ranking #910,633 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mike Bigler. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.